Jones Financial Companies
NPCE icon

Jones Financial Companies’s Neuropace NPCE Stock Holding History

Jones Financial Companies’s Portfolio NPCE Stock Details NPCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.53K Buy
+340
New +$5.1K ﹤0.01% 3883
2024
Q4 		– Sell
-1,000
Closed -$6.68K – 3475
2024
Q3 		$6.68K Hold
1,000
– – ﹤0.01% 2364
2024
Q2 		$7.56K Buy
+1,000
New +$10.1K ﹤0.01% 1844

Other funds holding NPCE

PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Jones Financial Companies's NPCE Position: Q1 2026 in Review

Jones Financial Companies opened a new position in Neuropace (NPCE) in Q1 2026: 340 shares worth $4.53K. The stake represents ﹤0.01% of the portfolio and ranks #3883 among its holdings. This is a return to the name: Jones Financial Companies previously reported a position in NPCE as recently as Q3 2024.

Jones Financial Companies first reported a position in NPCE in Q2 2024 and has held it in 3 quarters since. The position peaked at $7.56K in Q2 2024. 113 funds tracked by Wall St. Rank hold NPCE as of Q1 2026.

  • Jones Financial Companies held 340 shares of Neuropace worth $4.53K as of Q1 2026.
  • Neuropace was a new Jones Financial Companies position in Q1 2026.
  • Neuropace made up ﹤0.01% of Jones Financial Companies's portfolio in Q1 2026, its #3883 holding.
  • Jones Financial Companies first reported a position in Neuropace in Q2 2024 and has held it in 3 quarters since.
  • Jones Financial Companies's Neuropace position peaked at $7.56K in Q2 2024.
  • 113 funds tracked by Wall St. Rank held Neuropace as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.